top of page

News: Creating a Virus-Resistant Bacterium Using a Synthetic Engineered Genome.

Published 12:08 AM EST, Fri February 16, 2024

Genome engineering allows scientists to modify the genetic code of microbes. Now, researchers have engineered the genome of the bacterium Escherichia coli (E. coli) to make it immune to viral infections. These infections often cause bacterial cultures to fail.


 


 

Scientists have achieved a significant breakthrough in the field of genome engineering. They successfully modified the genetic code of E. coli bacteria, granting them immunity to viral infections. This innovation holds immense potential for biomanufacturing, where large bacterial cultures are used to produce valuable products like biofuels and chemicals.


Viral infections pose a major threat to these cultures, often leading to their collapse and halting production. This engineered E. coli strain possesses several built-in safety features. Firstly, it blocks the unwanted transfer of its engineered genes to other bacteria. Secondly, it requires a specific, non-natural amino acid to survive, effectively confining it to the lab environment.


This advancement holds great promise for expanding the applications and commercial viability of engineered microbes. Not only does it mitigate the risk of production shutdowns due to viral infections, but it also addresses concerns about engineered organisms escaping and impacting the environment.


The cannabis industry also heavily relies on microbial engineering, particularly for large-scale cannabinoid production. Similar vulnerabilities to viral infections and potential environmental risks exist in this domain. The technology showcased in this research could be adapted to engineer cannabis-specific microbes with enhanced viral resistance and robust biosafety measures. This would translate to improved production efficiency, reduced costs, and a more sustainable and environmentally responsible cannabis industry.


Source: Energy.gov

Weekly Breeder's Brief

suscribed!

  • Telegram
  • Instagram
  • LinkedIn
USA logo
Switzerland
Colombia

3300 6th Ave S, Seattle, WA 98134, US

Gartenstrasse 95, 4002 Basel, SW

Cra. 12a #78-40, Bogotá, CO

Copyright © 2019 a1phatype. All rights reserved. The content on this website is protected by copyright laws in the US and may not be reproduced, distributed, or transmitted in any form or by any means without the prior written permission of the copyright holder. We respect your privacy and are committed to protecting your personal data. Our Privacy Policy outlines how we collect, use, and protect your information. This website may contain links to third-party websites. These links are provided for your convenience only and do not signify our endorsement of the content on those websites. We have no control over the content of these websites and accept no responsibility for them.

 

Disclaimer: The information on this website is intended for educational and informational purposes only. It is not intended to promote, condone, or encourage the cultivation, possession, use, or distribution of cannabis or cannabis seeds in any way. Only Licensed Cannabis Producers and/or Researchers may contact Alphatype to discuss business opportunities. Alphatype will not entertain business opportunities with Unlicensed Companies or individuals. The content on this website is not legal advice and should not be relied upon as such.

bottom of page